1997 (Cycle III)
Collaboration Awards: CRC (Community Research Collaboration) Pilot Awards Top
| Increasing Annual Recall in State Early Detection Programs | ||||
| CHG Foundation | ||||
| Research Priority: Imaging, Biomarkers, & Molecular Pathology > Improved access to screening | ||||
| Award Type: CRC Pilot | ||||
| Breast Cancer Risk Factors: Lesbian & Heterosexual Women | ||||
| University of California, San Francisco | ||||
| Research Priority: Etiology > Environment & gene/environment interactions | ||||
| Award Type: CRC Pilot | ||||
Innovative Awards: IDEA (Innovative, Developmental, and Exploratory Awards) Top
| Nitric Oxide's Role in Breast Cancer Metabolism and Growth | ||||
| City of Hope National Medical Center | ||||
| Research Priority: Etiology > Other searches for the causes | ||||
| Award Type: IDEA | ||||
| Identification of Pregnancy-associated Breast Cancer Genes | ||||
| University of California, Berkeley | ||||
| Research Priority: Prevention & Risk Reduction > Other searches for the causes | ||||
| Award Type: IDEA | ||||
| Fate Mapping of Progesterone Receptor Positive Breast Cells | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: IDEA | ||||
| Does Cell Aging Cause Breast Cancer? | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Pathogenesis > Unraveling the path to breast cancer | ||||
| Award Type: IDEA | ||||
| Breast Cancer Incidence in California Flight Attendants | ||||
| Public Health Institute | ||||
| Research Priority: Etiology > Environment & gene/environment interactions | ||||
| Award Type: IDEA | ||||
| Recombination and Mutation in Breast Cancer | ||||
| Pangene Corporation | ||||
| Research Priority: Pathogenesis > Mistakes on the master blueprint | ||||
| Award Type: IDEA | ||||
| Analysis of Rac Mutations in Breast Cancer | ||||
| Scripps Research Institute | ||||
| Research Priority: Pathogenesis > Searching the unknown | ||||
| Award Type: IDEA | ||||
| Reprogramming Breast Cancer Epithelial Cells | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Unraveling the path to breast cancer | ||||
| Award Type: IDEA | ||||
| Estrogen Formation and Breast Cancer Risk | ||||
| University of Southern California | ||||
| Research Priority: Etiology > Hormones & nutrition | ||||
| Award Type: IDEA | ||||
| Autoantibodies in Breast Cancer | ||||
| Scripps Research Institute | ||||
| Research Priority: Pathogenesis > Unraveling the path to breast cancer | ||||
| Award Type: IDEA | ||||
| Vitamin D Receptor Gene and Breast Cancer Risk | ||||
| University of Southern California | ||||
| Research Priority: Etiology > Environment & gene/environment interactions | ||||
| Award Type: IDEA | ||||
| Growth Factor Receptor Activation in Breast Cancer | ||||
| Scripps Research Institute | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: IDEA | ||||
| Dietary Indole Inhibition of Breast Cancer | ||||
| University of California, Berkeley | ||||
| Research Priority: Prevention & Risk Reduction > Other searches for the causes | ||||
| Award Type: IDEA | ||||
| The Role of a Novel Estrogen Receptor in Breast Cancer | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: IDEA | ||||
| Novel Breast Cancer Epithelial Cell Metalloproteinase | ||||
| California Pacific Medical Center Research Institute | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: IDEA | ||||
| Molecular Karyotyping of Breast Cancer by DNA Fingerprinting | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Searching the unknown | ||||
| Award Type: IDEA | ||||
| Identifying Novel Breast Cancer Tumor Suppressor Genes | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Searching the unknown | ||||
| Award Type: IDEA | ||||
| Hormonal Control of HER2neu and BRCA1 in Breast Cancer | ||||
| Sidney Kimmel Cancer Center | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: IDEA | ||||
| Bovine Leukemia Virus and Human breast Cancer Risk | ||||
| University of California, Berkeley | ||||
| Research Priority: Etiology > Environment & gene/environment interactions | ||||
| Award Type: IDEA | ||||
Innovative Awards: ITaMoCAs Top
| Antibody Fusion Proteins for the Therapy of Breast Cancer | ||||
| University of California, Los Angeles | ||||
| Research Priority: Innovative Treatments > Immune therapy | ||||
| Award Type: ITaMoCAs | ||||
| Enhancing breast cancer sensitivity to chemotherapy | ||||
| Sidney Kimmel Cancer Center | ||||
| Research Priority: Innovative Treatments > Hormone and chemotherapy targets | ||||
| Award Type: ITaMoCAs | ||||
| Targeting T Cells to Breast Cancer | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Innovative Treatments > Immune therapy | ||||
| Award Type: ITaMoCAs | ||||
| Peptide-pulsed Dendritic Cell Therapy for Breast Cancer | ||||
| University of Southern California | ||||
| Research Priority: Innovative Treatments > Immune therapy | ||||
| Award Type: ITaMoCAs | ||||
| Gene Therapy for Breast Cancer | ||||
| California Pacific Medical Center Research Institute | ||||
| Research Priority: Innovative Treatments > Gene therapy & other treatments | ||||
| Award Type: ITaMoCAs | ||||
| Inhibitors of the Breast Cancer Her-2/neu Gene | ||||
| Scripps Research Institute | ||||
| Research Priority: Innovative Treatments > Hormone and chemotherapy targets | ||||
| Award Type: ITaMoCAs | ||||
| Blocking Stromelysin-3 to Inhibit Breast Cancer Metastasis | ||||
| SRI International | ||||
| Research Priority: Innovative Treatments > New drug design | ||||
| Award Type: ITaMoCAs | ||||
| Superfibronectin: A Novel Anti-Breast Cancer Agent | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Innovative Treatments > New drug design | ||||
| Award Type: ITaMoCAs | ||||
| Novel drugs to inhibit breast cancer metastasis | ||||
| University of California, Santa Cruz | ||||
| Research Priority: Innovative Treatments > New drug design | ||||
| Award Type: ITaMoCAs | ||||
| Receptor Antibody-Enhanced Chemotherapy for Breast Cancer | ||||
| Beckman Research Institute of the City of Hope | ||||
| Research Priority: Innovative Treatments > Immune therapy | ||||
| Award Type: ITaMoCAs | ||||
| Novel Enzyme Inhibitors for Estrogen-Dependent Breast Cancer | ||||
| SRI International | ||||
| Research Priority: Innovative Treatments > New drug design | ||||
| Award Type: ITaMoCAs | ||||
Career Development Awards: Postdoctoral Fellowship Top
| Control of DNA Replication in Breast Cancer | ||||
| Stanford University | ||||
| Research Priority: Pathogenesis > Mistakes on the master blueprint | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Breast Carcinoma Associated MAR-binding Proteins p90 and p70 | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Pathogenesis > Searching the unknown | ||||
| Award Type: Postdoctoral Fellowship | ||||
| ECM-Regulated Transcription in Breast Cancer | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Pathogenesis > Mistakes on the master blueprint | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Modulation of Drug Resistance by Protein Kinase C Inhibitors | ||||
| Stanford University | ||||
| Research Priority: Innovative Treatments > Immune therapy | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Physical Activity, Diet and Menarche in a Multiethnic Cohort | ||||
| University of Southern California | ||||
| Research Priority: Etiology > Hormones & nutrition | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Disruption of Cyclin E/Cell Cycle In Breast Cancer Cells | ||||
| Scripps Research Institute | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Integrin Activation in the Metastasis of Breast Cancer | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Bovine Leukemia Virus and Mammary Cell Infection | ||||
| University of California, Berkeley | ||||
| Research Priority: Etiology > Environment & gene/environment interactions | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Regulation of Wnt: Clues for breast cancer pathognesis | ||||
| University of California, Irvine | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: Postdoctoral Fellowship | ||||
| TRAF-regulated Signal Transduction in Breast Cancer | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Hormone Receptors and Breast Cancer Survival | ||||
| University of Southern California | ||||
| Research Priority: Etiology > Hormones & nutrition | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Characterization of Heregulin Targeted Genes | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Pathogenesis > Searching the unknown | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Molecular Analysis of BRCA1 Function | ||||
| Salk Institute for Biological Studies | ||||
| Research Priority: Pathogenesis > Mistakes on the master blueprint | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Integrin Receptor Activation in Breast Cancer | ||||
| Scripps Research Institute | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: Postdoctoral Fellowship | ||||
Topic-targeted Research Awards: RFA (Request for Applications) Top
| Hormonal Control of Normal Breast Tissue | ||||
| Cancer Research Institute of Contra Costa | ||||
| Research Priority: Biology of the Normal Breast > Breast development | ||||
| Award Type: RFA | ||||
| Breast Cancer Chemoprevention by Retinoids | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Biology of the Normal Breast > Breast development | ||||
| Award Type: RFA | ||||
| Mammogram Density, Cancer, Inheritance & Acquired Risk:Twins | ||||
| University of Southern California | ||||
| Research Priority: Etiology > Environment & gene/environment interactions | ||||
| Award Type: RFA | ||||
| The Role of PAK2 in Breast Cancer Cell Death | ||||
| Scripps Research Institute | ||||
| Research Priority: Biology of the Normal Breast > Breast aging | ||||
| Award Type: RFA | ||||
| Organochlorine Insecticides and Breast Cancer | ||||
| University of California, Davis | ||||
| Research Priority: Biology of the Normal Breast > Breast function | ||||
| Award Type: RFA | ||||
| Gene-Diet/Tobacco Interactions in Breast Cancer in Asians | ||||
| University of Southern California | ||||
| Research Priority: Etiology > Hormones & nutrition | ||||
| Award Type: RFA | ||||
| Genetic Repair of Oxidative Damage: Effect of Estrogen | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Biology of the Normal Breast > Breast function | ||||
| Award Type: RFA | ||||
Collaboration Awards: TRC (Translational Research Collaboration) Pilot Awards Top
| Biochemical Correlates for Clinical Response to Paclitaxel | ||||
| University of Southern California | ||||
| Research Priority: Innovative Treatments > Hormone and chemotherapy targets | ||||
| Award Type: TRC Pilot | ||||
| Inhibition of Angiogenesis in Breast Cancer | ||||
| University of California, San Francisco | ||||
| Research Priority: Innovative Treatments > Gene therapy & other treatments | ||||
| Award Type: TRC Pilot | ||||
